ARTICLE | Clinical News
Ezogabine regulatory update
September 6, 2010 7:00 AM UTC
Valeant and partner GlaxoSmithKline said FDA extended the PDUFA date for an NDA for ezogabine to Nov. 30 from Aug. 30. The partners attributed the delay to Valeant's submission of a formal REMS for ez...